| Issue | Title | |
| Vol 4, Issue 4 (2024) | Improving Technologies to Preventive Approaches in Psychiatry | Abstract PDF (Eng) |
| O. A. Skugarevsky | ||
| Vol 6, Issue 3 (2026) | Individualization of Pharmacotherapy | Abstract PDF (Eng) |
| Sergey B. Seredenin | ||
| Vol 2, Issue 1 (2022) | Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk | Abstract PDF (Eng) |
| N. M. Zhuravlev, N. A. Shnayder, E. E. Vaiman, A. K. Abdyrakhmanova, M. M. Petrova, E. N. Bochanova, I. V. Romanova, O. A. Gavrilyuk, N. V. Lareva, R. F. Nasyrova | ||
| Vol 6, Issue 3 (2026) | Intravenous Valproic Acid for Treatment-Resistant Psychomotor Agitation: A Case Series | Abstract PDF (Eng) |
| Vladimir L. Kozlovsky, Natalia V. Semenova, Mikhail Yu. Popov, Dmitry N. Kosterin, Olga V. Lepik, A. Yu. Goncharenko, Svetlana V. Lyashkovskaya | ||
| Vol 1, Issue 2 (2021) | Juvenile myoclonic epilepsy: current state of the problem | Abstract PDF (Eng) |
| N. A. Shnayder, K. V. Petrov | ||
| Vol 5, Issue 3 (2025) | Legal Aspects of Personalized Medicine | Abstract PDF (Eng) |
| Oleg S. Grin | ||
| Vol 4, Issue 2 (2024) | Limitations of the Use of Animal Models of Acute Myocardial Infarction for Experimental Studies of Vascular Cognitive Dysfunction: Brief Review | Abstract PDF (Eng) |
| A. V. Petrov, A. A. Evsyukov, M. M. Petrova, N. A. Shnayder | ||
| Vol 4, Issue 4 (2024) | Modern Psychiatry: from Theory to Practice | Abstract PDF (Eng) |
| N. N. Petrova | ||
| Vol 2, Issue 2 (2022) | Modifiable and Non-Modifiable Predictors of Dupuytren’s Disease | Abstract PDF (Eng) |
| A. V. Petrov, G. V. Medvedev, D. V. Pushkin, L. A. Rodomanova, M. M. Petrova | ||
| Vol 5, Issue 1 (2025) | Monocyte-to-Lymphocyte Ratio Any Association with Metabolic Syndrome in Schizophrenia | Abstract PDF (Eng) |
| N. V. Zakharova, A. V. Kidyaeva, V. V. Grechkina, I. R. Boyko, A. I. Rakhmatullin, M. V. Tabak, R. F. Nasyrova | ||
| 61 - 70 of 129 Items | << < 2 3 4 5 6 7 8 9 10 11 > >> | |
Browse Title Index
Popular articles
Vol 2, Issue 1 (2022)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Keywords
Parkinson's disease
adverse drug reaction
adverse drug reactions
adverse reaction
antipsychotic
antipsychotics
biomarkers
candidate genes
clozapine
efficacy
epilepsy
genetics
long QT syndrome
metabolic syndrome
personalized medicine
pharmacogenetic testing
pharmacogenetics
safety
schizophrenia
single nucleotide variant
therapeutic resistance
3, Bekhterev street, bldg. 6, 192019, Saint-Petersburg, Russian Federation
Telephone: +7 (812) 670 02 20, add. 7813, 7814
E-mail: journal.ppnn@gmail.com
